Technology | August 02, 2011

First Liquid-Filled 2-D Ion Chamber Array From PTW Assesses SBRT Quality Assurance

Aug. 2, 2011 — The accurate determination of dose in very small fields poses great challenges for high-precision radiation therapy. With Octavius Detector 1000, which was developed for the dosimetric verification of very small fields, PTW has developed a technology to aid stereotactic body radiation therapy (SBRT) and stereotactic radio surgery (SRS) quality assurance (QA).

The new liquid-filled 2-D ion chamber array combines the advantages of ion chambers and solid state detectors, offering a spatial resolution and field coverage as only known from film measurement. It will be on showcase at the Joint AAPM/COMP Meeting in Vancouver, Canada, July 31 – Aug. 4 2011.

??The Octavius Detector is the first commercially available 2-D flat-panel detector array to employ liquid-filled ionization chambers.

Liquid-filled ionization chambers show an excellent signal-to-noise ratio even for very small volumes. They are thus capable of providing high spatial resolution, which is particularly useful for dose determination in very small radiation fields and high dose gradients as encountered in stereotaxy and radiosurgery. Other than solid state detectors, however, liquid-filled ion chambers have a density very close to water and a superior surface coverage. These particular characteristics put them in the same line with dosimetric films. ??

With 977 liquid-filled ionization chambers, each as small as 2 x 2 x 0.4 mm, and a spatial resolution of only 2.5 mm, the array delivers highly accurate dose measurements for field sizes of less than 1 cm x 1 cm up to 10 cm x 10 cm. It will be available by the end of 2011.??

For more information: www.ptwny.com

Related Content

DOSIsoft Receives FDA 510(k) Clearance for Planet Onco Dose Software
Technology | Information Technology | June 20, 2019
DOSIsoft announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Planet...
New Data Demonstrates Safety Profile of GammaTile Therapy for Various Brain Tumors
News | Brachytherapy Systems | June 18, 2019
GT Medical Technologies Inc. announced the presentation of clinical data from a prospective study of GammaTile Therapy...
Black Men Less Likely to Adopt Active Surveillance for Low-Risk Prostate Cancer
News | Prostate Cancer | June 17, 2019
A new study reveals black men are less likely than white men to adopt an active surveillance strategy for their...
University Medical Center Groningen Performs First Automatic Log-based Proton Therapy Patient QA
News | Proton Therapy | June 14, 2019
IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and...
ASTRO Applauds New Prior Authorization Legislation
News | Radiation Therapy | June 07, 2019
The American Society for Radiation Oncology (ASTRO) released a statement applauding Congress’s introduction of...
IBA Dosimetry Launches myQA iON
News | Quality Assurance (QA) | June 07, 2019
IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...
RefleXion Opens New Manufacturing Facility for Biology-guided Radiotherapy Platform
News | Radiation Therapy | May 31, 2019
RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward,...
Accuray Radixact

Accuray Radixact

Feature | Radiation Therapy | May 29, 2019 | By Jeff Zagoudis
While radiation therapy as a disciplin
Sponsored Content | Case Study | Radiation Therapy | May 29, 2019
The so-called “Grey Tsunami” of baby boomers using healthcare services isn’t taking the Radiation Medicine Program at